Ethopharmacological evaluation of the rat exposure test: A prey-predator interaction test

Behavioural Brain Research

Volumn 240, Issue 1, 2013, Pages 160-170

  Campos, Kelciane Ferreira Caetano ^a,b   Amaral, Vanessa Cristiane Santana ^a,b,c   Rico, Javier Leonardo ^a,d   Miguel, Tarciso Tadeu ^a,b,e   Nunes de Souza, Ricardo Luiz ^a,b,e  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

^c Unidade Universitária de Ciências Exatas e Tecnológicas   (Brazil)

^d FUNDACIÓN UNIVERSITARIA KONRAD LORENZ   (Colombia)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Factor analysis; Mice; Panicogenic drugs; Panicolytic drugs; Prey predator interaction; Rat exposure test

Indexed keywords

ALPRAZOLAM; CAFFEINE; DIAZEPAM; FLUOXETINE; IMIPRAMINE; SEROTONIN 1A RECEPTOR; SEROTONIN 2 RECEPTOR; YOHIMBINE;

ACUTE DRUG ADMINISTRATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; ATTENUATION; AVERSIVE BEHAVIOR; BEHAVIOR CHANGE; BODY POSTURE; CHRONIC DRUG ADMINISTRATION; CLIMBING; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG POTENCY; EXPERIMENTAL TEST; GROOMING; LOCOMOTION; LONG TERM EXPOSURE; MALE; MOUSE; NONHUMAN; PANIC; PREDATOR AVOIDANCE; PREDATOR PREY INTERACTION; PRIORITY JOURNAL; RAT; RAT EXPOSURE TEST; VALIDATION PROCESS;

ADRENERGIC ALPHA-2 RECEPTOR ANTAGONISTS; ALPRAZOLAM; ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DIAZEPAM; ESCAPE REACTION; FACTOR ANALYSIS, STATISTICAL; FLUOXETINE; FOOD CHAIN; IMIPRAMINE; MALE; MICE; MOTOR ACTIVITY; POSTURE; PREDATORY BEHAVIOR; RATS; RATS, LONG-EVANS; TIME FACTORS; YOHIMBINE;

EID: 84871387916     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.11.023     Document Type: Article

References (65)

1. Blanchard D.C., Griebel G., Rodgers R.J., Blanchard R.J. Benzodiazepine and serotonergic modulation of antipredator and conspecific defense. Neuroscience and Biobehavioral Reviews 1998, 22:597-612.
2. Blanchard D.C., Griebel G., Blanchard R.J. Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic. Neuroscience and Biobehavioral Reviews 2001, 25:205-218.
3. Jardim M.C., Nogueira R.L., Graeff F.G., Nunes-de-Souza R.L. Evaluation of the elevated T-maze as an animal model of anxiety in the mouse. Brain Research Bulletin 1999, 48:407-411.
4. Yang M., Augustsson H., Markham C.M., Hubbard D.T., Webster D., Wall P.M., et al. The rat exposure test: a model of mouse defensive behaviors. Physiology and Behavior 2004, 81:465-473.
5. Karli P. The Norway rat's killing response to the white mouse: an experimental analysis. Behaviour 1956, 10:81-103.
6. O'Boyle M. Rats and mice together: the predatory nature of the rat's mouse-killing response. Psychological Bulletin 1974, 81(4):261-269.
7. O'Boyle M. The rat as a predator. Psychological Bulletin 1975, 82:460-462.
8. Rylov A.L. Changes in predatory and intraspecific aggressiveness of the male rat during food deprivation. Zhurnal Vysshei Nervnoi Deiatelnosti Imeni IP Pavlova 1985, 35(5):875-878.
9. Blanchard D.C., Griebel G., Pobbe R., Blanchard R.J. Risk assessment as an evolved threat detection and analysis process. Neuroscience and Biobehavioral Reviews 2011, 35(4):991-998.
10. Pobbe R.L., Zangrossi H., Blanchard D.C., Blanchard R.J. Involvement of dorsal raphe nucleus and dorsal periaqueductal gray 5-HT receptors in the modulation of mouse defensive behaviors. European Neuropsychopharmacology 2011, 21(4):306-315.
11. Blanchard D.C., Blanchard R.J., Griebel G. Defensive responses to predator threat in the rat and mouse. Current Protocols in Neuroscience 2005, [Chapter 8: Unit 8.19].
12. McNaughton N., Corr P.J. A two-dimensional neuropsychology of defense: fear/anxiety and defensive distance. Neuroscience and Biobehavioral Reviews 2004, 28:285-305.
13. Wall P.M., Blanchard R.J., Markham C., Yang M., Blanchard D.C. Infralimbic D1 receptor agonist effects on spontaneous novelty exploration and anxiety-like defensive responding in CD-1 mice. Behavioural Brain Research 2004, 152(1):67-79.
14. Carvalho-Netto E.F., Litvin Y., Nunes-de-Souza R.L., Blanchard D.C., Blanchard R.J. Effects of intra-PAG infusion of ovine CRF on defensive behaviors in Swiss-Webster mice. Behavioural Brain Research 2007, 176(2):222-229.
15. Carvalho-Netto E.F., Gomes K.S., Amaral V.C.S., Nunes-de-Souza R.L. Role of glutamate NMDA receptors and nitric oxide located within the periaqueductal gray on defensive behaviors in mice confronted by predator. Psychopharmacology 2009, 204(4):617-625.
16. Litvin Y., Pentkowski N.S., Blanchard D.C., Blanchard R.J. CRF type 1 receptors in the dorsal periaqueductal gray modulate anxiety-induced defensive behaviors. Hormones and Behavior 2007, 52:244-251.
17. Tovote P., Farrokhi C.B., Gonzales R.M., Schnitzabauer U. Activation of central CRF receptor 1 by cortagine results in enhanced passive coping with a naturalistic threat in mice. Psychoneuroendocrinology 2010, 35(6):887-895.
18. Martinez R.C.R., Carvalho-Netto E.F., Amaral V.C.S., Nunes-de-Souza R.L., Canteras N.S. Investigation of the hypothalamic defensive system in the mouse. Behavioural Brain Research 2008, 192:185-190.
19. Amaral V.C.S., Gomes K.S., Nunes-de-Souza R.L. Increased corticosterone levels in mice subjected to the rat exposure test. Hormones and Behavior 2010, 57:128-133.
20. Canteras N.S., Kroon J.A., Do-Monte F.H., Pavesi E., Carobrez A.P. Sensing danger through the olfactory system: the role of the hypothalamic dorsal premammillary nucleus. Neuroscience and Biobehavioral Reviews 2008, 32(7):1228-1235.
21. Dielenberg R.A., Hunt G.E., McGregor I.S. When a rat smells a cat: the distribution of Fos immunoreactivity in rat brain following exposure to a predatory odor. Neuroscience 2001, 104:1085-1097.
22. Carvalho-Netto E.F., Nunes-de-Souza R.L. Use of the elevated T-maze to study anxiety in mice. Behavioural Brain Research 2004, 148:119-132.
23. Gomes K.S., Carvalho-Netto E.F., Monte K.C., Acco B., Nogueira P.J., Nunes-de-Souza R.L. Contrasting effects of acute and chronic treatment with imipramine and fluoxetine on inhibitory avoidance and escape responses in mice exposed to the elevated T-maze. Brain Research Bulletin 2009, 78(6):323-327.
24. Menon M.K., Vivonia C.A. Serotonergic drugs, benzodiazepines and baclofen block muscimol-induced myoclonic jerks in a strain of mice. European Journal of Pharmacology 1981, 73(2-3):155-161.
25. Smith K.S., Meloni E.G., Myers K.M., Van'tVeer A., Carlezon W.A., Rudolph A. Reduction of fear-potentiated startle by benzodiazepines in C57BL/6J mice. Psychopharmacology 2011, 213(4):697-706.
26. Rodgers R.J., Johnson J.T. Factor analysis of spatiotemporal and ethological measures in the murine plus-maze test of anxiety. Pharmacology Biochemistry and Behavior 1995, 52(2):297-303.
27. Tovote P., Farrokhi C.B., Gonzales R.M.K., Schnitzbauer U., Blanchard D.C., Blanchard R.J., et al. Activation of central CRF receptor 1 by cortagine results in enhanced passive coping with a naturalistic threat in mice. Psychoneuroendocrinology 2010, 35(6):887-895.
28. Cruz A.P., Frei F., Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus maze. Pharmacology Biochemistry and Behavior 1994, 49(1):171-176.
29. Archer J. Tests for emotionality in rats and mice: a review. Animal Behaviour 1973, 21:205-235.
30. Misslin R., Belzung C., Vogel E. Behavioural validation of a light/dark choice procedure for testing anti-anxiety agents. Behavioural Processes 1989, 8:119-132.
31. Crawley J., Goodwin F.K. Anxiogenic-like effects of mCPP microinfusions into the amygdala (but not dorsal or ventral hippocampus) in mice exposed to elevated plus-maze. Pharmacology Biochemistry and Behavior 1980, 13(2):167-170.
32. Griebel G., Perrault G., Tan S., Schoemaker H., Sanger D.J. Comparison of the pharmacological properties of classical and novel BZ-omega receptor ligands. Behavioural Pharmacology 1999, 10(5):483-495.
33. Cole J.C., Rodgers R.J. An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze. Behavioural Pharmacology 1993, 4(6):573-580.
34. Griebel G., Perrault G., Sanger D.J. Characterization of the behavioral profile of the nonpeptide CRF receptor antagonist CP-154,526 in anxiety models in rodents-comparison with diazepam and buspirone. Psychopharmacology 1998, 138:55-66.
35. Tesar G.E., Rosenbaum J.F., Pollack M.H., Otto M.W., Sachs G.S., Herman J.B., et al. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder. Journal of Clinical Psychiatry 1991, 52(2):69-76.
36. Graeff F.G., Ferreira Neto C., Zangrossi H. The elevated T-maze as an experimental model of anxiety. Neuroscience and Biobehavioral Reviews 1998, 23:237-246.
37. Shimada T., Matsumoto K., Osanai M., Matsuda H., Terasawa K., Watanabe H. The modified light/dark transition test in mice: evaluation of classic and putative anxiolytic and anxiogenic drugs. General Pharmacology 1995, 26:205-210.
38. Johnson A.L., File S.E. Yohimbine's anxiogenic action: evidence for noradrenergic and dopaminergic sites. Pharmacology Biochemistry and Behavior 1989, 32:151-156.
39. Cole J.C., Burroughs G.J., Laverty C.R., Sheriff N.C., Sparham E.A., Rodgers R.J. Anxiolytic-like effects of yohimbine in the murine plus-maze: strain independence and evidence against alpha-2 adrenoceptor mediation. Psychopharmacology 1995, 118(4):425-436.
40. Baldwin H.A., Jhonston A.L., File S.E. Antagonistic effects of caffeine and yohimbine in animal tests of anxiety. European Journal of Pharmacology 1989, 159:211-215.
41. De Vry I., Benz U., Schreiber R., Traber J. Shock-induced ultrasonic vocalization in Young adult rats: a model for testing putative anti-anxiety drugs. European Journal of Pharmacology 1993, 249(3):331-339.
42. Griebel G., Blanchard D.C., Jung A., Masuda C.K., Blanchard R.J. 5-HT1A agonists modulate mouse antipredator defensive behavior differently from the 5-HT2A antagonist pirenperone. Pharmacology Biochemistry and Behavior 1995, 51(2-3):235-244.
43. Poltronieri S.C., Zangrossi H., Viana M.B. Antipanic-like effect of serotonin reuptake inhibitors in the elevated T-maze. Behavioural Brain Research 2003, 147:185-192.
44. Nunes-de-Souza R.L., Canto-de-Souza A., Da-Costa M., Fornari R.V., Graeff F.G., Pelá I.R. Anxiety-induced antinociception in mice: effects of systemic and intra-amygdala administration of 8-OH-DPAT and midazolam. Psychopharmacology 2000, 150:300-310.
45. Rodgers R.J., Cole J.C., Cobain M.R., Daly P., Doran P.J., Eells J.R., et al. Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze: profile comparisons with 8-OH-DPAT, CGS 12066B, TFMPP and mCPP. Behavioural Pharmacology 1992, 3:621-634.
46. Blanchard R.J., Griebel G., Henrie J.A., Blanchard D.C. Differentiation of anxiolytic and panicolytic drugs by effects on rat and mouse defense test batteries. Neuroscience and Biobehavioral Reviews 1997, 21:783-789.
47. Young R., Johnson D.N. A fully automated light/dark apparatus useful for comparing anxiolytic agents. Pharmacology Biochemistry and Behavior 1991, 40(4):739-743.
48. Zuardi A.W., Cosme R.A., Graeff F.G., Guimarães F.S. Effects of ipsapirone and cannabidiol on human experimental anxiety. Journal of Psychopharmacology 1993, 7:82-88.
49. Cole J.C., Rodgers R.J. Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol. Psychopharmacology 1994, 114:288-296.
50. Yamashita S., Oishi R., Gomita Y. Anticonflict effects of acute and chronic treatments with buspirone and gepirone in rats. Pharmacology Biochemistry and Behavior 1995, 50:477-479.
51. Deakin J.G., Graeff F.G. 5-HT and mechanisms of defence. Journal of Psychopharmacology 1991, 5(4):305-315.
52. Kuznetsova E.G., Amstislavskaya T.G., Bulygina W., Tiblikina M.A., Popova N.K. Effect of 5HT2c-receptor agonist MK-212 on blood corticosterone level and behavior in mice. Bulletin of Experimental Biology and Medicine 2006, 142(5):594-597.
53. Brookshire B.R., Jones S.R. Direct and indirect 5-HT receptor agonists produce gender-specific effects on locomotor and vertical activities in C57 BL/6J mice. Pharmacology Biochemistry and Behavior 2004, 94:194-203.
54. Mora P.O., Netto C.F., Graeff F.G. Role of 5-HT2A and 5-HT2C receptor subtypes in the two types of fear generated by the elevated T-maze. Pharmacology Biochemistry and Behavior 1997, 58(4):1051-1057.
55. de Mello Cruz A.P., Pinheiro G., Alves S.H., Ferreira G., Mendes M., Faria L., et al. Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze. Psychopharmacology 2005, 182(3):345-354.
56. Cornélio A.M., Nunes-de-Souza R.L. Anxiogenic-like effects of mCPP microinfusions into the amygdala (but not dorsal or ventral hippocampus) in mice exposed to elevated plus-maze. Behavioural Brain Research 2007, 178(1):82-89.
57. Nunes-de-Souza V., Nunes-de-Souza R.L., Rodgers R.J., Canto-de-Souza A. 5-HT2 receptor activation in the midbrain periaqueductal grey (PAG) reduces anxiety-like behaviour in mice. Behavioural Brain Research 2008, 187(1):72-79.
58. Burghardt N.S., Bush D.E., McEwen B.S., LeDoux J.E. Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist. Biological Psychiatry 2007, 62(10):1111-1118.
59. Enginar N., Hatipoĝlu I., Firtina M. Evaluation of the acute effects of amitriptyline and fluoxetine on anxiety using grooming analysis algorithm in rats. Pharmacology Biochemistry and Behavior 2008, 89(3):450-455.
60. Ravinder S., Pillai A.G., Chattarji S. Cellular correlates of enhanced anxiety caused by acute treatment with the selective serotonin reuptake inhibitor fluoxetine in rats. Frontiers in Behavioral Neuroscience 2011, 5(88):1-9.
61. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 1987, 92:180-185.
62. Pellow S., Chopin P., File S.E., Brilley M. Validation of open: closed arm entries m an elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Methods 1985, 14:149-167.
63. Briley M., Chopin P., Veagner M. The " plus-maze test of anxiety": validation in different rat strains and effect of a wide variety of antidepressants. British Journal of Pharmacology 1986, 87(Suppl. 1):217.
64. Gillman P.K. Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. British Journal of Pharmacology 2007, 151(6):737-748.
65. Teixeira R.C., Zangrossi H., Graeff F.G. Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety. Pharmacology Biochemistry and Behavior 2000, 65(4):571-576.